| 赫 捷,陈万青,沈洪兵,等.中国人群肝癌筛查指南（2022，北京）[J].中国肿瘤,2022,31(8):587-631. |
| 中国人群肝癌筛查指南（2022，北京） |
| China Guideline for Liver Cancer Screening (2022， Beijing) |
| 投稿时间：2022-08-04 |
| DOI：10.11735/j.issn.1004-0242.2022.08.A002 |
|
 |
| 中文关键词: 肝肿瘤 筛查 监测 指南 中国 |
| 英文关键词:liver neoplasms screening surveillance guideline China |
| 基金项目: |
|
| 摘要点击次数: 707 |
| 全文下载次数: 220 |
| 中文摘要: |
| 摘 要：中国人群的肝癌存在生存率低、死亡率高的情况，如何有效降低肝癌相关负担仍是中国公共卫生和慢性病防控领域亟待解决的重大问题，而肝癌人群筛查策略优化是值得持续探索的重要抓手和方向。中国人群肝癌筛查指南受国家卫生健康委员会疾病预防控制局委托，由国家癌症中心发起，联合多学科专家，根据世界卫生组织推荐的指南制定原则和方法，整合肝癌人群筛查领域的国内外研究新证据，兼顾中国国情及实践经验，针对肝癌筛查过程中的筛查人群、筛查技术、监测方案等呈现循证推荐，以期为中国人群肝癌筛查实践的规范提供参考。 |
| 英文摘要: |
| Abstract： In China， the survival rate of liver cancer remains low while the mortality rate is high. Effectively reducing the burden of liver cancer is still a major challenge in the field of public health and chronic disease prevention among the Chinese population. Optimizing screening strategies for liver cancer remains a profound approach to secondary prevention worthy of continuous exploration. To address this pressing issue， the Bureau of Disease Control and Prevention of the National Health Commission commissioned this guideline. The National Cancer Center of China initiated the guideline development and convened a multidisciplinary expert panel and working groups. Following the World Health Organization Handbook for Guideline Development， this guideline integrated the most up-to-date evidence of liver cancer screening， China’s national conditions， and existing practical experience in liver cancer screening. Evidence-based recommendations on the target population， screening technologies， surveillance strategies， and other key points across the process of liver cancer screening and surveillance management were provided. This guideline would help standardize the practice of liver cancer screening in China. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |
|
|
|